Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 5/20 | 0.74 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | ERN1 | O75460 | 1/20 | 0.55 |
| ▸ | MAOB | P27338 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.43 |
| ▸ | TUBB | P07437 | 1/20 | 0.43 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.43 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.43 |
| ▸ | TUBA4A | P68366 | 1/20 | 0.43 |
| ▸ | TUBB4B | P68371 | 1/20 | 0.43 |
| ▸ | TUBB3 | Q13509 | 1/20 | 0.43 |
| ▸ | TUBB2A | Q13885 | 1/20 | 0.43 |
| ▸ | TUBB8 | Q3ZCM7 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30277943 | 1.00 | CYP3A4 (0.74) | CYP3A4USP2MAPK1SMN1; SMN2ERN1 | |
| 2,6-Dihydroxy-4-Methoxytoluene SCHEMBL1607351 | 0.85 | CYP3A4 (1.00) | CYP3A4USP2MAPK1SMN1; SMN2ERN1 | |
| SCHEMBL69301 | 0.84 | CYP3A4 (0.56) | CYP3A4MAOBPTPN1MAPTCA1 | |
| SCHEMBL862161 | 0.83 | ALDH1A1 (0.56) | CYP3A4USP2MAPK1SMN1; SMN2ERN1 | |
| Methoxymethane SCHEMBL28032536 | 0.82 | CYP3A4 (0.54) | CYP3A4MAOBPTPN1MAPTCA1 | |
| SCHEMBL4445709 | 0.81 | CYP3A4 (0.59) | CYP3A4USP2MAPK1SMN1; SMN2ERN1 | |
| SCHEMBL29888627 | 0.79 | CYP3A4 (0.57) | CYP3A4USP2MAPK1SMN1; SMN2ERN1 | |
| SCHEMBL12586702 | 0.79 | CYP3A4 (0.77) | CYP3A4USP2MAPK1SMN1; SMN2ERN1 | |
| SCHEMBL10053940 | 0.79 | ACHE (0.59) | CYP3A4MAPK1SMN1; SMN2ERN1MAOB | |
| SCHEMBL1402215 | 0.77 | CYP3A4 (0.60) | CYP3A4USP2MAPK1SMN1; SMN2ERN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250290009-A1 | NEW LOW SULFUR TERPENE MIX RECOVERY FROM WOOD PROCESSING | FIRMENICH SA (CH) | 2025-09-18 | — | — | US | claimed |
| EP-4522714-A1 | NEW LOW SULFUR TERPENE MIX RECOVERY FROM WOOD PROCESSING | Firmenich SA (CH) | 2025-03-19 | — | — | EP | claimed |
| WO-2023217712-A1 | NEW LOW SULFUR TERPENE MIX RECOVERY FROM WOOD PROCESSING | FIRMENICH SA (CH) | 2023-11-16 | — | — | WO | claimed |
| CN-112602785-A | Fat-soluble natural antioxidant and preparation method and application thereof | 江苏利田科技股份有限公司 | 2021-04-06 | — | — | CN | claimed |
| US-20250290009-A1 | NEW LOW SULFUR TERPENE MIX RECOVERY FROM WOOD PROCESSING | FIRMENICH SA (CH) | 2025-09-18 | — | — | US | disclosed |
| EP-4522714-A1 | NEW LOW SULFUR TERPENE MIX RECOVERY FROM WOOD PROCESSING | Firmenich SA (CH) | 2025-03-19 | — | — | EP | disclosed |
| EP-4153555-B1 | PHOTOOXIDATION OF PHENOLIC COMPOUNDS | DSM IP ASSETS BV (NL) | 2024-01-31 | — | — | EP | disclosed |
| WO-2023217712-A1 | NEW LOW SULFUR TERPENE MIX RECOVERY FROM WOOD PROCESSING | FIRMENICH SA (CH) | 2023-11-16 | — | — | WO | disclosed |
| EP-4153555-A1 | PHOTOOXIDATION OF PHENOLIC COMPOUNDS | DSM IP Assets B.V. (NL) | 2023-03-29 | — | — | EP | disclosed |
| CN-115667201-A | Photooxidation of phenolic compounds | 帝斯曼知识产权资产管理有限公司 | 2023-01-31 | — | — | CN | disclosed |
| WO-2021234080-A1 | PHOTOOXIDATION OF PHENOLIC COMPOUNDS | DSM IP ASSETS B.V. (NL) | 2021-11-25 | — | — | WO | disclosed |
| CN-109293493-B | Novel benzhydryl compounds with mycobacterium tuberculosis inhibiting activity | 清华大学 | 2021-08-03 | — | — | CN | disclosed |
| US-20060105970-A1 | Avermectins substituted in the 4\"-position having pesticidal properties | SYNGENTA CROP PROTECTION, INC. | 2006-05-18 | — | — | US | disclosed |
| CN-1704424-A | Novel acyclic nucleoside phosphonate and its medical use | BEIJING FU KANG REN BIO PHARM (CN) | 2005-12-07 | — | — | CN | disclosed |
| CN-1670024-A | Acyclic nucleoside phosphonate derivatives | INST PHARM & TOXICOLOGY AMMS (CN) | 2005-09-21 | — | — | CN | disclosed |
| WO-2003068233-A1 | NICOTINAMIDE DERIVATIVES AND A TIOTROPIUM SALT IN COMBINATION FOR THE TREATMENT OF E.G. INFLAMMATORY, ALLERGIC AND RESPIRATORY DISEASES | PFIZER LIMITED (GB) | 2003-08-21 | — | — | WO | disclosed |
| WO-2003068235-A1 | NICOTINAMIDE DERIVATIVES USEFUL AS PDE4 INHIBITORS | PFIZER LIMITED (GB) | 2003-08-21 | — | — | WO | disclosed |
| EP-0489836-B1 | LIGHT ACTIVATED ACYL-ENZYMES | UNIV DUKE (US) | 1994-12-21 | — | — | EP | disclosed |
| US-5218137-A | Chemical light amplifiers | DUKE UNIVERSITY (US) | 1993-06-08 | — | — | US | disclosed |
| US-5114851-A | Serine- or cysteine-containing protease modified by nucleophilic cinnamic acid; photoisomerization; biological switches; medical diagnosis | DUKE UNIVERSITY (US) | 1992-05-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060105970-A1 | Avermectins substituted in the 4\"-position having pesticidal properties | DDT, C3AR1, C9 | CYP3A4 58/4885USP2 1348/4885MAPK1 4260/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.